Finished product reference
Acetaminophen / Chlorpheniramine / Dextromethorphan / Phenylephrine
Syrup · Oral · 160 mg/1 mg/5 mg/2.5 mg/5mL · 120 mL
- List code
- 50341
- Pharmacologic class
- Combination cold and cough preparation (analgesic-antipyretic, antihistamine, antitussive, decongestant)
What it is and how it works
Paracetamol relieves pain and fever; chlorphenamine is a sedating H1-antihistamine; dextromethorphan suppresses the cough reflex centrally; phenylephrine is an alpha-1 agonist nasal decongestant.
Indications
Short-term symptomatic relief of common cold and influenza symptoms including fever, nasal congestion, rhinorrhoea and dry, non-productive cough.
Contraindications
Hypersensitivity to any component; severe hypertension or coronary artery disease; use with or within 14 days of MAO inhibitors; severe hepatic impairment; young children (under 6 years) for cough and cold combinations.
Warnings and precautions
Avoid other paracetamol-containing products. May cause drowsiness; avoid alcohol and driving. Use with caution in hypertension, hyperthyroidism, diabetes, glaucoma and urinary retention; dextromethorphan may interact with serotonergic drugs.
Pregnancy
Generally avoided in pregnancy, particularly in the first trimester.
Storage and supply
Store below 25 °C, protected from light; do not freeze.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.